Global X Genomics & Biotechnology ETF Rating $8.10 -0.09 (-1.10%) Closing price 04/25/2025 03:59 PM EasternExtended Trading$8.02 -0.07 (-0.93%) As of 04/25/2025 04:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Global X Genomics & Biotechnology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.GNOM Aggregate RatingModerate Buy 2.66Holdings in GNOM have an aggregate rating of Moderate Buy based on 505 analyst ratings issued in the past year covering 38 companies (96.2% of the portfolio).GNOM Aggregate Price Target$8.10High Prediction$8.10Average Prediction$8.10Low Prediction$8.10Holdings in GNOM have an aggregate price target of $8.10 and a range of $8.10 to $8.10 covering 38 companies (96.2% of the portfolio).GNOM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy5 Buy rating(s)Moderate Buy20 Moderate Buy rating(s)Hold12 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Global X Genomics & Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 39 GNOM Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.93%NTRANatera$153.79-0.4%3.0173 of 5 stars3.00$175.76 14.3%16Insider TradeNews CoveragePositive News5.53%QGENQiagen$42.10-2.2%3.6208 of 5 stars2.27$47.83 13.6%115.41%VCYTVeracyte$32.23+0.3%3.9017 of 5 stars2.70$42.60 32.2%10Analyst RevisionNews Coverage5.02%BMRNBioMarin Pharmaceutical$63.30+0.9%4.9231 of 5 stars2.70$93.14 47.1%23Upcoming EarningsAnalyst UpgradePositive News4.67%ALNYAlnylam Pharmaceuticals$251.56+3.7%4.6231 of 5 stars2.77$315.58 25.5%26Upcoming EarningsAnalyst UpgradePositive News4.64%BNTXBioNTech$102.02-15.4%2.3666 of 5 stars2.89$143.44 40.6%18Analyst RevisionHigh Trading Volume4.63%AAgilent Technologies$106.31-0.7%4.779 of 5 stars2.46$143.00 34.5%134.48%TECHBio-Techne$50.24-1.1%4.8455 of 5 stars2.38$81.14 61.5%8Upcoming Earnings4.18%CRSPCRISPR Therapeutics$38.27-2.1%2.7395 of 5 stars2.48$73.11 91.0%214.09%LEGNLegend Biotech$34.28+0.1%2.2631 of 5 stars2.92$78.82 129.9%12Analyst Forecast3.59%GILDGilead Sciences$103.17-2.8%4.5623 of 5 stars2.78$109.43 6.1%27Earnings ReportDividend AnnouncementAnalyst ForecastAnalyst RevisionNews CoverageGap Down3.49%RAREUltragenyx Pharmaceutical$38.09+1.2%4.4435 of 5 stars2.93$92.79 143.6%14Upcoming Earnings3.33%RNAAvidity Biosciences$30.84-0.3%2.238 of 5 stars3.00$66.69 116.3%13Positive News3.08%BEAMBeam Therapeutics$19.52-3.2%3.0265 of 5 stars3.00$49.45 153.4%14Options Volume3.06%ARWRArrowhead Pharmaceuticals$13.25-0.7%3.5129 of 5 stars2.60$41.44 212.8%10Positive News3.05%ILMNIllumina$77.35-0.3%4.598 of 5 stars2.48$138.70 79.3%21Positive News3.00%VRTXVertex Pharmaceuticals$493.84+0.3%4.0316 of 5 stars2.64$514.91 4.3%25Analyst ForecastAnalyst RevisionPositive News2.85%MRNAModerna$27.22-0.6%4.3687 of 5 stars2.04$58.70 115.7%24Upcoming EarningsNews CoverageGap Down2.46%CDNACareDx$18.48-0.1%3.765 of 5 stars2.57$30.33 64.1%7Upcoming EarningsNews CoveragePositive News2.40%SRPTSarepta Therapeutics$60.44-2.1%4.6312 of 5 stars2.83$158.70 162.6%242.12%TXG10x Genomics$8.30-0.1%4.6088 of 5 stars2.35$19.79 138.4%17Upcoming EarningsAnalyst ForecastNews CoveragePositive News1.98%MYGNMyriad Genetics$7.42+0.7%4.0012 of 5 stars2.19$20.61 177.7%16Analyst RevisionNews CoverageHigh Trading Volume1.83%NTLAIntellia Therapeutics$8.31+1.6%4.5438 of 5 stars2.65$36.68 341.4%20Analyst Revision1.37%VIRVir Biotechnology$6.12-2.7%2.7759 of 5 stars2.86$33.57 448.6%7Upcoming EarningsNews Coverage1.22%RCKTRocket Pharmaceuticals$7.23-2.7%4.6046 of 5 stars2.92$43.00 494.7%12News Coverage1.11%QUREuniQure$14.18-0.6%2.3806 of 5 stars2.82$38.80 173.6%110.96%PACBPacific Biosciences of California$1.09-4.4%2.6641 of 5 stars2.50$2.45 124.8%10Positive News0.95%FLGTFulgent Genetics$18.88-0.8%3.2217 of 5 stars2.00$16.00 -15.3%1Upcoming EarningsNews CoveragePositive News0.74%RGNXREGENXBIO$9.15-0.5%4.6127 of 5 stars2.83$31.63 245.6%6Positive News0.69%TSVT2seventy bio$4.98-0.2%2.1516 of 5 stars2.29$5.60 12.4%7Upcoming EarningsAnalyst ForecastNews Coverage0.66%MRVIMaravai LifeSciences$2.05-1.0%4.2639 of 5 stars2.18$6.34 209.5%110.59%VERVVerve Therapeutics$5.76-0.3%3.2188 of 5 stars3.00$25.75 347.0%6Positive News0.57%ALLOAllogene Therapeutics$1.55-1.3%3.0503 of 5 stars2.90$9.29 499.3%10News Coverage0.53%SANASana Biotechnology$1.772.3 of 5 stars2.86$10.80 510.2%7Analyst Forecast0.39%SGMOSangamo Therapeutics$0.79-3.4%2.1589 of 5 stars2.67$5.17 556.5%60.22%EDITEditas Medicine$1.54-4.3%4.0157 of 5 stars2.07$6.83 343.7%140.17%LYELLyell Immunopharma$0.45-3.6%3.2826 of 5 stars1.50$1.00 122.1%2Positive News0.17%CRBUCaribou Biosciences$0.77-11.3%2.4346 of 5 stars3.00$10.33 1,235.1%5News Coverage0.00%SCLXScilex$4.67+5.4%2.0649 of 5 stars2.60$455.00 9,643.0%5Gap DownHigh Trading Volume This page (NASDAQ:GNOM) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Genomics & Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
